With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
This fascinating basic science investigation reveals histamine receptors in the tumor microenvironment as an oncogenic immuno-evasive strategy that can be ameliorated with the simple addition of an antihistamine to immunotherapy. | Li, Cancer Cell 2021
Comments
Post a Comment